Cargando…

Arrhythmia induced cardiomyopathy

Arrhythmia induced cardiomyopathies (AIC) refer to the collective condition of Arrhythmia, Tachycardia, and ectopy‐induced Cardiomyopathy. Atrial fibrillation (AF) and heart failure (HF) are modern epidemics that often coexist and exacerbate one another. We aim to provide an overview of the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugumar, Hariharan, Prabhu, Sandeep, Voskoboinik, Aleksandr, Kistler, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111481/
https://www.ncbi.nlm.nih.gov/pubmed/30167008
http://dx.doi.org/10.1002/joa3.12094
_version_ 1783350666259857408
author Sugumar, Hariharan
Prabhu, Sandeep
Voskoboinik, Aleksandr
Kistler, Peter M.
author_facet Sugumar, Hariharan
Prabhu, Sandeep
Voskoboinik, Aleksandr
Kistler, Peter M.
author_sort Sugumar, Hariharan
collection PubMed
description Arrhythmia induced cardiomyopathies (AIC) refer to the collective condition of Arrhythmia, Tachycardia, and ectopy‐induced Cardiomyopathy. Atrial fibrillation (AF) and heart failure (HF) are modern epidemics that often coexist and exacerbate one another. We aim to provide an overview of the current understanding and evidence for treatment and management in AIC with a particular focus on AF‐mediated cardiomyopathy and suggest approaches to recognize, screen, and manage AIC.
format Online
Article
Text
id pubmed-6111481
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61114812018-08-30 Arrhythmia induced cardiomyopathy Sugumar, Hariharan Prabhu, Sandeep Voskoboinik, Aleksandr Kistler, Peter M. J Arrhythm Special Issue: Risk Stratification and Specific Management Arrhythmia induced cardiomyopathies (AIC) refer to the collective condition of Arrhythmia, Tachycardia, and ectopy‐induced Cardiomyopathy. Atrial fibrillation (AF) and heart failure (HF) are modern epidemics that often coexist and exacerbate one another. We aim to provide an overview of the current understanding and evidence for treatment and management in AIC with a particular focus on AF‐mediated cardiomyopathy and suggest approaches to recognize, screen, and manage AIC. John Wiley and Sons Inc. 2018-07-20 /pmc/articles/PMC6111481/ /pubmed/30167008 http://dx.doi.org/10.1002/joa3.12094 Text en © 2018 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Special Issue: Risk Stratification and Specific Management
Sugumar, Hariharan
Prabhu, Sandeep
Voskoboinik, Aleksandr
Kistler, Peter M.
Arrhythmia induced cardiomyopathy
title Arrhythmia induced cardiomyopathy
title_full Arrhythmia induced cardiomyopathy
title_fullStr Arrhythmia induced cardiomyopathy
title_full_unstemmed Arrhythmia induced cardiomyopathy
title_short Arrhythmia induced cardiomyopathy
title_sort arrhythmia induced cardiomyopathy
topic Special Issue: Risk Stratification and Specific Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111481/
https://www.ncbi.nlm.nih.gov/pubmed/30167008
http://dx.doi.org/10.1002/joa3.12094
work_keys_str_mv AT sugumarhariharan arrhythmiainducedcardiomyopathy
AT prabhusandeep arrhythmiainducedcardiomyopathy
AT voskoboinikaleksandr arrhythmiainducedcardiomyopathy
AT kistlerpeterm arrhythmiainducedcardiomyopathy